PL3524260T3 - Kompozycje farmaceutyczne do leczenia braku apetytu - Google Patents

Kompozycje farmaceutyczne do leczenia braku apetytu

Info

Publication number: PL3524260T3
Authority: PL; Poland
Prior art keywords: inappetence; treatment; pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 2012-09-27

Application number

PL19161662.2T

Other languages

English (en)

Inventor

Bill ZOLLERS

Linda RHODES

Ernst Heinen

Gopinath DEVARAJ

Original Assignee

Elanco Animal Health Incorporated

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-09-27

Filing date

2013-09-27

Publication date

2023-11-27

2013-09-27 Application filed by Elanco Animal Health Incorporated filed Critical Elanco Animal Health Incorporated

2023-11-27 Publication of PL3524260T3 publication Critical patent/PL3524260T3/pl

Links

206010061428 decreased appetite Diseases 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Polymers & Plastics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Animal Husbandry (AREA)
Food Science & Technology (AREA)
Epidemiology (AREA)
Birds (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fodder In General (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Feed For Specific Animals (AREA)
Dermatology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PL19161662.2T 2012-09-27 2013-09-27 Kompozycje farmaceutyczne do leczenia braku apetytu PL3524260T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201261706164P	2012-09-27	2012-09-27

Publications (1)

Publication Number	Publication Date
PL3524260T3 true PL3524260T3 (pl)	2023-11-27

Family

ID=50339468

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL19161662.2T PL3524260T3 (pl)	2012-09-27	2013-09-27	Kompozycje farmaceutyczne do leczenia braku apetytu

Country Status (18)

Country	Link
US (1)	US11090292B2 (pl)
EP (3)	EP4302825A3 (pl)
JP (2)	JP6779618B2 (pl)
KR (5)	KR20190143484A (pl)
CN (2)	CN105072909A (pl)
AR (2)	AR092713A1 (pl)
AU (2)	AU2013323349B2 (pl)
BR (1)	BR112015006282B1 (pl)
CA (1)	CA2886091C (pl)
DK (1)	DK3524260T3 (pl)
ES (1)	ES2959427T3 (pl)
MX (2)	MX2015003564A (pl)
NZ (2)	NZ707174A (pl)
PL (1)	PL3524260T3 (pl)
PT (1)	PT3524260T (pl)
RU (1)	RU2648958C2 (pl)
TW (3)	TW202106298A (pl)
WO (1)	WO2014052780A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPWO2011105611A1 (ja)	2010-02-26	2013-06-20	ラクオリア創薬株式会社	悪液質を治療するためのグレリン受容体作動物質
WO2013119800A1 (en)	2012-02-07	2013-08-15	Massachusetts Institute Of Technology	Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
WO2014052780A2 (en)	2012-09-27	2014-04-03	Aratana Therapeutics, Inc.	Compositions and methods of use of an inappetance-controlling compound
WO2014144231A1 (en)	2013-03-15	2014-09-18	Massachusetts Institute Of Technology	Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
US9700591B2 (en) *	2015-01-28	2017-07-11	Aratana Therapeutics, Inc.	Compositions and methods for chronic use of a weight-gaining compound
US10317418B2 (en)	2015-02-24	2019-06-11	Massachusetts Institute Of Technology	Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
RU2732320C1 (ru) *	2016-11-11	2020-09-15	Хиллс Пет Нутришн, Инк.	Кормовые композиции для домашних животных и способы их получения и применения

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US193273A (en) *		1877-07-17		Improvement in material for pulley-covers
JP2893901B2 (ja) *	1990-09-07	1999-05-24	株式会社岐阜免疫研究所	動物用抗体含有油性ペースト製剤
CA2095786A1 (en)	1992-05-08	1993-11-09	Franco J. Vaccarino	Method of stimulating appetite
TW432073B (en)	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
ATE446758T1 (de)	2000-05-31	2009-11-15	Pfizer Prod Inc	Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
EP1181933A3 (en)	2000-06-29	2002-04-10	Pfizer Products Inc.	Use of growth hormone secretagogues for stimulating or increasing appetite
US8309603B2 (en)	2004-06-07	2012-11-13	University Of Tennessee Research Foundation	SARMs and method of use thereof
US7491695B2 (en) *	2003-06-18	2009-02-17	Tranzyme Pharma Inc.	Methods of using macrocyclic modulators of the ghrelin receptor
US7476653B2 (en) *	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
CA2603295A1 (en) *	2004-04-07	2006-10-20	Gastrotech Pharma A/S	Use of ghrelin for the treatment of hyperthyroidism
WO2006045313A2 (en) *	2004-10-27	2006-05-04	Gastrotech Pharma A/S	Uses of secretagogues for treatment of organ transplant patients
AU2006310690B2 (en)	2005-11-02	2012-05-31	Société des Produits Nestlé S.A.	Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
JP5325092B2 (ja) *	2006-03-13	2013-10-23	リアット・ミンツ	悪液質および／または食欲不振症および／または食欲不振症−悪液質および／または栄養失調および／または脂肪異栄養症および／または筋肉消耗および／または食欲−刺激を治療するためのグレリンスプライス変異体の使用
NZ576470A (en)	2006-09-27	2012-09-28	Ipsen Pharma Sas	Analogs of ghrelin substituted at the n-terminal
JP2008127377A (ja) *	2006-11-24	2008-06-05	Jichi Medical Univ	Ｇｈｓ−ｒ作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。
US20080226802A1 (en) *	2007-03-14	2008-09-18	Concentrate Manufacturing Company Of Ireland	Beverage having natural sweeteners with one or more stevia components and source of berry
TWI429436B (zh) *	2007-04-10	2014-03-11	Helsinn Therapeutics Us Inc	使用生長激素促泌素治療或預防嘔吐之方法
RU2007129408A (ru) *	2007-07-31	2009-02-10	Игорь Николаевич Жирков (RU)	Способ выращивания поросят в период откорма
FR2920295B1 (fr)	2007-09-05	2009-12-11	Desvac	Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable
WO2009063921A1 (ja) *	2007-11-12	2009-05-22	San-Ei Gen F.F.I., Inc.	ステビア抽出物の甘味質改善
PE20120618A1 (es)	2009-03-26	2012-06-05	Takeda Pharmaceutical	Compuestos de pirazol como inhibidores de la bomba de protones
JPWO2011105611A1 (ja) *	2010-02-26	2013-06-20	ラクオリア創薬株式会社	悪液質を治療するためのグレリン受容体作動物質
WO2014052780A2 (en)	2012-09-27	2014-04-03	Aratana Therapeutics, Inc.	Compositions and methods of use of an inappetance-controlling compound

2013
- 2013-09-27 WO PCT/US2013/062227 patent/WO2014052780A2/en active Application Filing
- 2013-09-27 DK DK19161662.2T patent/DK3524260T3/da active
- 2013-09-27 CA CA2886091A patent/CA2886091C/en active Active
- 2013-09-27 TW TW109121986A patent/TW202106298A/zh unknown
- 2013-09-27 CN CN201380061931.6A patent/CN105072909A/zh active Pending
- 2013-09-27 AU AU2013323349A patent/AU2013323349B2/en active Active
- 2013-09-27 CN CN202010001164.1A patent/CN111419845A/zh active Pending
- 2013-09-27 EP EP23191187.6A patent/EP4302825A3/en active Pending
- 2013-09-27 KR KR1020197037811A patent/KR20190143484A/ko active Application Filing
- 2013-09-27 KR KR1020237019962A patent/KR20230097201A/ko not_active Application Discontinuation
- 2013-09-27 KR KR1020157009647A patent/KR20150058345A/ko not_active IP Right Cessation
- 2013-09-27 KR KR1020217042990A patent/KR20220003640A/ko not_active IP Right Cessation
- 2013-09-27 US US14/039,114 patent/US11090292B2/en active Active
- 2013-09-27 PT PT191616622T patent/PT3524260T/pt unknown
- 2013-09-27 RU RU2015114996A patent/RU2648958C2/ru active
- 2013-09-27 JP JP2015534747A patent/JP6779618B2/ja active Active
- 2013-09-27 TW TW102135177A patent/TWI667024B/zh active
- 2013-09-27 NZ NZ707174A patent/NZ707174A/en active IP Right Revival
- 2013-09-27 EP EP13841455.2A patent/EP2906041A4/en not_active Withdrawn
- 2013-09-27 KR KR1020217001509A patent/KR20210009438A/ko not_active Application Discontinuation
- 2013-09-27 NZ NZ746394A patent/NZ746394A/en unknown
- 2013-09-27 MX MX2015003564A patent/MX2015003564A/es active IP Right Grant
- 2013-09-27 PL PL19161662.2T patent/PL3524260T3/pl unknown
- 2013-09-27 AR ARP130103486A patent/AR092713A1/es not_active Application Discontinuation
- 2013-09-27 EP EP19161662.2A patent/EP3524260B1/en active Active
- 2013-09-27 BR BR112015006282-2A patent/BR112015006282B1/pt active IP Right Grant
- 2013-09-27 ES ES19161662T patent/ES2959427T3/es active Active
- 2013-09-27 TW TW107142255A patent/TWI732158B/zh active
2015
- 2015-03-19 MX MX2022015141A patent/MX2022015141A/es unknown
2016
- 2016-08-22 AU AU2016216741A patent/AU2016216741B2/en active Active
2018
- 2018-03-07 JP JP2018041063A patent/JP6796097B2/ja active Active
2021
- 2021-10-22 AR ARP210102942A patent/AR123902A2/es unknown

Also Published As

Publication number	Publication date
EP3524260B1 (en)	2023-09-13
NZ707174A (en)	2018-10-26
MX2015003564A (es)	2015-11-16
WO2014052780A3 (en)	2014-06-26
CN105072909A (zh)	2015-11-18
KR20220003640A (ko)	2022-01-10
CA2886091C (en)	2021-11-30
AU2013323349A1 (en)	2015-05-07
TW201417812A (zh)	2014-05-16
TWI732158B (zh)	2021-07-01
JP2016500660A (ja)	2016-01-14
US11090292B2 (en)	2021-08-17
MX2022015141A (es)	2023-02-01
US20140088139A1 (en)	2014-03-27
EP4302825A2 (en)	2024-01-10
ES2959427T3 (es)	2024-02-26
AU2016216741A1 (en)	2016-09-15
TW201924680A (zh)	2019-07-01
JP6779618B2 (ja)	2020-11-04
AU2016216741B2 (en)	2018-02-15
BR112015006282A2 (pt)	2017-07-04
KR20230097201A (ko)	2023-06-30
TW202106298A (zh)	2021-02-16
EP4302825A3 (en)	2024-07-03
KR20210009438A (ko)	2021-01-26
AR092713A1 (es)	2015-04-29
KR20150058345A (ko)	2015-05-28
DK3524260T3 (da)	2023-10-09
EP3524260A1 (en)	2019-08-14
JP2018117625A (ja)	2018-08-02
EP2906041A4 (en)	2016-10-26
KR20190143484A (ko)	2019-12-30
CN111419845A (zh)	2020-07-17
WO2014052780A2 (en)	2014-04-03
AU2013323349B2 (en)	2016-09-15
RU2015114996A (ru)	2016-11-20
EP2906041A2 (en)	2015-08-19
PT3524260T (pt)	2023-10-13
BR112015006282B1 (pt)	2021-11-23
AR123902A2 (es)	2023-01-25
RU2648958C2 (ru)	2018-03-28
CA2886091A1 (en)	2014-04-03
JP6796097B2 (ja)	2020-12-02
TWI667024B (zh)	2019-08-01
NZ746394A (en)	2019-01-25

Publication	Publication Date	Title
HK1212701A1 (zh)	2016-06-17	恩雜魯胺製劑
HK1206297A1 (en)	2016-01-08	Pharmaceutical compositions for combination therapy
HUE044611T2 (hu)	2019-11-28	Gyógyászati készítmény rák kezelésére
PL2824114T3 (pl)	2019-11-29	Kompozycja farmaceutyczna do leczenia nowotworu
LT2854768T (lt)	2017-06-12	Pemetreksedo farmacinės kompozicijos
HRP20190050T1 (hr)	2019-03-08	Farmaceutski pripravci za kombinacijsku terapiju
EP2917314A4 (en)	2016-06-29	OLIGOMERATZUSAMMENSETZUNG
EP2897613A4 (en)	2016-03-30	TREATMENT COMPOSITIONS
PL3524260T3 (pl)	2023-11-27	Kompozycje farmaceutyczne do leczenia braku apetytu
PL2887924T3 (pl)	2017-09-29	Kompozycje farmaceutyczne etorykoksybu
HK1207566A1 (en)	2016-02-05	Compositions for improvement of brain function
GB201100786D0 (en)	2011-03-02	Pharmaceutical compositions of immunosuppressants
HK1206633A1 (en)	2016-01-15	Composition for treatment of warts
IL236870B (en)	2019-11-28	History of hydroxystatin for the treatment of osteoarthritis
HK1213809A1 (zh)	2016-07-15	用於治療肥胖症的藥物組合物
PT2814473T (pt)	2019-01-21	Composições farmacêuticas para terapia de combinação
GB201212717D0 (en)	2012-08-29	Treatment of musculoskeletal conditions
HUE039044T2 (hu)	2018-12-28	Gyógyászati kompozíció sclerosis multiplex kezelésére